• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Top 5 FDA-Cleared Apps for Primary Care

Slideshow

From a mobile EKG monitor to a digital urinalysis app, these medical "devices" are changing the way healthcare is delivered.

Recent Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose / image credit: ©New Africa/AdobeStock

US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose

Sydney Jennings
November 22nd 2024
Article

Your daily dose of the clinical news you may have missed.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research / Image credit: ©valiantsin/AdobeStock

New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research

Sydney Jennings
November 20th 2024
Article

The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Intensive SBP Reduction Below 120 mm Hg Reduces MACE in Adults with Type 2 Diabetes / image credit ©Yi Zhang

Intensive SBP Reduction Below 120 mm Hg Reduces MACE in Adults with Type 2 Diabetes

Grace Halsey
November 18th 2024
Article

AHA 2024. Findings from the BPROAD trial help fill a gap left by similar studies on the ideal target SBP for adults with type 2 diabetes, said study authors.

©Kurhan/AdobeStock

Aprocitentan Now Available in the US for Treatment-Resistant Hypertension

Sydney Jennings
November 15th 2024
Article

Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.

© 2024 MJH Life Sciences

All rights reserved.